Authors

• Margarida Gonçalo (ORCID: https://orcid.org/0000-0001-6842-1360)
• Amy Praestgaard
• Joseph Zahn
• Tsukasa Ugajin (ORCID: https://orcid.org/0000-0002-4111-6224)
• Ashish Bansal (ORCID: https://orcid.org/0000-0002-7371-6486)
• Simmi Wiggins (ORCID: https://orcid.org/0009-0006-2880-1995)
• Brian Kim (ORCID: https://orcid.org/0000-0002-8100-7161)
• Melanie Makhija
• Xinghua Gao (ORCID: https://orcid.org/0009-0004-0130-9859)

Institutions

• BG Group (United Kingdom) (GB)
• Regeneron (United States) (US)
• Hospitais da Universidade de Coimbra (PT)
• Tokyo Institute of Psychiatry (JP)
• Sanofi (United States) (US)
• First Hospital of China Medical University (CN)
• University of Coimbra (PT)
• China Medical University (CN)
• Icahn School of Medicine at Mount Sinai (US)

Publication Details

Journal

American Journal of Clinical Dermatology

Published

2025-11-11

DOI

https://doi.org/10.1007/s40257-025-00993-1

Primary Topic

Dermatology and Skin Diseases

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Sanofi
• Regeneron Pharmaceuticals